Search Browse Earnings

Lunai Bioworks Inc.

Nasdaq:LNAI

Pharmaceutical Preparations·SUITE 906 LOS ANGELES, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Weinstein David Hershel

CFO

Fuentes Nathen

Revenue

$0

FY 2011

Adj. EBITDA

-$81.5M

FY 2025

Net Income

-$88.4M

FY 2025

EPS (Diluted)

-$0.91

FY 2025

Stock Price

$0.22

-39.4%

2026-03-09

52W Range

$0.23 – $9.00

P/E Ratio

-0.2x

Market Cap

$5.3M

Cash

$220,467

FY 2025

Total Debt

$4.7M

FY 2016

Net Debt

$4.5M

FY 2016

Enterprise Value

$9.8M

Debt / EBITDA

-0.1x

FY 2011

EV / EBITDA

-0.1x

Employees

—